Artículos por temáticas

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Zang WB, Wei HL, Zhang WW, Ma W, Li J, Yao Y.

Eur J Med Chem. 2024 Feb 5;265:116070. doi: 10.1016/j.ejmech.2023.116070. Epub 2023 Dec 18.

Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden

Lyon M, Fullerton JL, Kennedy S, Work LM.

Pharmacol Ther. 2024 Jan;253:108575. doi: 10.1016/j.pharmthera.2023.108575. Epub 2023 Dec 3.

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

García-Culebras A, Cuartero MI, Peña-Martínez C, Moraga A, Vázquez-Reyes S, de Castro-Millán FJ, Cortes-Canteli M, Lizasoain I, Moro MÁ.

Br J Pharmacol. 2024 Mar;181(6):777-798. doi: 10.1111/bph.16159. Epub 2023 Jul 7.

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy

Soltan OM, Abdelrahman KS, Bass AKA, Takizawa K, Narumi A, Konno H.

Bioorg Chem. 2024 Oct;151:107651. doi: 10.1016/j.bioorg.2024.107651. Epub 2024 Jul 15.

Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review

Pei J, Palanisamy CP, Natarajan PM, Umapathy VR, Roy JR, Srinivasan GP, Panagal M, Jayaraman S.

Ageing Res Rev. 2024 Aug;99:102393. doi: 10.1016/j.arr.2024.102393. Epub 2024 Jun 24.

Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles

Liu X, Shen L, Wan M, Xie H, Wang Z.

J Nanobiotechnology. 2024 Apr 12;22(1):170. doi: 10.1186/s12951-024-02428-1.

Resveratrol: Protective Agent Against Alzheimer's Disease

Subhan I, Siddique YH.

Cent Nerv Syst Agents Med Chem. 2024;24(3):249-263. doi: 10.2174/0118715249287167240222081517.

Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease

Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y.

Biosci Trends. 2024 Nov 15;18(5):413-430. doi: 10.5582/bst.2024.01306. Epub 2024 Oct 11.

Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases

Saleem A, Javed M, Akhtar MF, Sharif A, Akhtar B, Naveed M, Saleem U, Baig MMFA, Zubair HM, Bin Emran T, Saleem M, Ashraf GM.

Curr Gene Ther. 2024;24(2):122-134. doi: 10.2174/0115665232261931231006103234.

Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies

Azzini E, Peña-Corona SI, Hernández-Parra H, Chandran D, Saleena LAK, Sawikr Y, Peluso I, Dhumal S, Kumar M, Leyva-Gómez G, Martorell M, Sharifi-Rad J, Calina D.

Phytother Res. 2024 Jun;38(6):3169-3189. doi: 10.1002/ptr.8200. Epub 2024 Apr 14.

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

Negi M, Amulya E, Phatale V, Abraham N, Hedaoo A, Srinivasarao DA, Srivastava S.

Life Sci. 2024 Dec 1;358:123155. doi: 10.1016/j.lfs.2024.123155. Epub 2024 Oct 19.

Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?

Mamun AA, Shao C, Geng P, Wang S, Xiao J.

Int J Biol Sci. 2024 Jan 27;20(4):1332-1355. doi: 10.7150/ijbs.90982. eCollection 2024.

Exploring the Therapeutic Potential of BBB-Penetrating Phytochemicals With p38 MAPK Modulatory Activity in Addressing Oxidative Stress-Induced Neurodegenerative Disorders, With a Focus on Alzheimer's Disease

Hosseini A, Sheibani M, Valipour M.

Phytother Res. 2024 Dec;38(12):5598-5625. doi: 10.1002/ptr.8329. Epub 2024 Sep 19.

Medication Exposure and Risk of Dementia and Alzheimer's Disease

Sharma N, An SSA, Kim SY.

Int J Mol Sci. 2024 Nov 29;25(23):12850. doi: 10.3390/ijms252312850.

Irisin in ischemic stroke, Alzheimer's disease and depression: a Narrative Review

Zhang QX, Zhang LJ, Zhao N, Yang L.

Brain Res. 2024 Dec 15;1845:149192. doi: 10.1016/j.brainres.2024.149192. Epub 2024 Aug 28.